Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.700
-0.030-0.39%
Volume:139.50M
Turnover:1.06B
Market Cap:88.70B
PE:19.05
High:7.750
Open:7.600
Low:7.420
Close:7.730
Loading ...

BRIEF-CSPC Pharmaceutical Says Sys6017 Obtained Clinical Trial Approval From NMPA

Reuters
·
07 Feb

CSPC Pharmaceutical - Sys6017 (Herpes Zoster Mrna Vaccine) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
07 Feb

CSPC Pharmaceutical Gets China Nod for Registration of Tumor Drug

MT Newswires Live
·
21 Jan

BRIEF-Cspc Pharmaceutical Says Regorafenib Tablets Obtains Drug Registration Approval

Reuters
·
20 Jan

CSPC Pharmaceutical - Regorafenib Tablets Obtains Drug Registration Approval From Nmpa China

THOMSON REUTERS
·
20 Jan

BRIEF-CSPC Pharmaceutical Says Sys6043 Obtains Clinical Trial Approval

Reuters
·
16 Jan

CSPC Pharmaceutical Gets FDA Approval for Clinical Trial of Tumor Drug in US

MT Newswires Live
·
16 Jan

CSPC Pharmaceutical - Sys6043 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
16 Jan

CSPC Pharmaceutical Gets Marketing Nod for Glycemic Control Drug in China

MT Newswires Live
·
13 Jan

CSPC Pharmaceutical - Prusogliptin Tablets Obtains Marketing Approval Granted by Nmpa

THOMSON REUTERS
·
13 Jan

Earnings growth of 1.5% over 5 years hasn't been enough to translate into positive returns for CSPC Pharmaceutical Group (HKG:1093) shareholders

Simply Wall St.
·
11 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
10 Jan

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtained Clinical Trial Approval

Reuters
·
10 Jan

CSPC Pharmaceutical - Sys6041 Obtains Clinical Trial Approval

THOMSON REUTERS
·
10 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYH2059 Tablets Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYS6045 Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

CSPC Pharmaceutical - Approval Granted by National Medical Products Administration

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical - Syh2059 Tablets Obtains Clinical Trial Approval

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical's Lung Cancer Drug Receives Breakthrough Therapy Designation in China

MT Newswires Live
·
03 Jan